# Anthropic buys Mithril Medicine

AI & tech · Heat 6.8 / 10 · 3 shows · 13m airtime

Anthropic announced on October 27, 2026, a drug discovery partnership with Bristol-Myers Squibb and its acquisition of Mithril Medicine, a biotech founded by one person. The founder used Claude and part-time consultants to take a muscular dystrophy antibody from concept to mouse proof of principle in 18 months, and Anthropic says it could be trial-ready by the end of 2028. The discussion has since widened: the 326-page IPO paperwork uses the word reputation 103 times, and disclosed acquisitions total about $737 million excluding Coefficient Bio, with roughly $260 million undisclosed. Whether the deal is validation or marketing ahead of the listing remains contested.

Page: https://boilpoints.com/point/anthropic_buys_mithril_medicine_1724968993

## Segments

- [The AI Daily Brief](https://boilpoints.com/u/theaidailybrief), 2026-10-28, 1:27 to 6:16: **Covers the acquisition and rounds up the reaction**. Covers Anthropic's drug discovery blog post, the Bristol-Myers Squibb partnership and the Mithril Medicine acquisition, then rounds up the reaction: the one-person-company debate, Scorpion Capital's dig at the founder's banking background, and the read that it is IPO marketing. New angle: Anthropic acquired Mithril Medicine, a one-person biotech whose founder used Claude to reach mouse proof of principle on a muscular dystrophy antibody in 18 months.
- [The Best One Yet](https://boilpoints.com/u/thebestoneyet), 2026-10-29, 10:29 to 14:53: **Recasts the acquisition as a solopreneur story**. Tells the acquisition as a solopreneur story: the anonymous @prof_oak_ turns out to be Cody Tranbarger, who ran 11 labs with Claude as his staff. Reads the deal as a reputation play, counting the word reputation 103 times in Anthropic's 326-page IPO paperwork. New angle: Anthropic's 326-page IPO paperwork uses the word reputation 103 times.
- [Equity](https://boilpoints.com/u/equity), 2026-10-30, 17:31 to 21:26: **Puts a $737M figure on the acquisitions**. Walks the S-1's acquisition line and puts a number on it: about $737 million excluding Coefficient Bio, with roughly $260 million undisclosed. Frames the buying as part of a perpetual growth machine that has to keep spending on compute. New angle: Anthropic's disclosed acquisitions total about $737 million excluding Coefficient Bio, with roughly $260 million undisclosed.